Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Studies on the inactivation of human parvovirus 4.

Baylis SA, Tuke PW, Miyagawa E, Bl├╝mel J.

Transfusion. 2013 Oct;53(10 Pt 2):2585-92. doi: 10.1111/trf.12372. Epub 2013 Aug 19.

PMID:
24032592
2.

No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.

Robinson MJ, Tuke PW, Erlwein O, Tettmar KI, Kaye S, Naresh KN, Patel A, Walker MM, Kimura T, Gopalakrishnan G, Tedder RS, McClure MO.

Adv Virol. 2011;2011:782353. doi: 10.1155/2011/782353. Epub 2011 Jun 9.

3.

Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?

Sayer R, Paul J, Tuke PW, Hargreaves S, Noursadeghi M, Tedder RS, Grant P, Edwards SG, Miller RF.

Int J STD AIDS. 2011 Oct;22(10):585-9. doi: 10.1258/ijsa.2011.010464.

PMID:
21998180
4.

PCR master mixes harbour murine DNA sequences. Caveat emptor!

Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS.

PLoS One. 2011;6(5):e19953. doi: 10.1371/journal.pone.0019953. Epub 2011 May 25.

5.

Parvovirus PARV4 visualization and detection.

Tuke PW, Parry RP, Appleton H.

J Gen Virol. 2010 Feb;91(Pt 2):541-4. doi: 10.1099/vir.0.014852-0. Epub 2009 Oct 21.

PMID:
19846677
6.

Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.

Tuke PW, Grant PR, Waite J, Kitchen AD, Eglin RP, Tedder RS.

Transfusion. 2008 Apr;48(4):594-600. doi: 10.1111/j.1537-2995.2007.01584.x. Epub 2008 Jan 11.

PMID:
18194388
7.

Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation.

Fryer JF, Delwart E, Bernardin F, Tuke PW, Lukashov VV, Baylis SA.

J Gen Virol. 2007 Aug;88(Pt 8):2162-7.

PMID:
17622618
8.

The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.

Leong HN, Tuke PW, Tedder RS, Khanom AB, Eglin RP, Atkinson CE, Ward KN, Griffiths PD, Clark DA.

J Med Virol. 2007 Jan;79(1):45-51.

PMID:
17133548
9.

Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains.

Tuke PW, Hawke S, Griffiths PD, Clark DA.

Mult Scler. 2004 Aug;10(4):355-9.

PMID:
15327029
10.

Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis.

Gaudin P, Ijaz S, Tuke PW, Marcel F, Paraz A, Seigneurin JM, Mandrand B, Perron H, Garson JA.

Rheumatology (Oxford). 2000 Sep;39(9):950-4.

PMID:
10986298
11.

Detection of reverse transcriptase activity in the serum of patients with motor neurone disease.

Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, Garson JA.

J Med Virol. 2000 Aug;61(4):527-32.

PMID:
10897073
12.

Absence of human retrovirus 5 in French patients with rheumatoid arthritis: comment on the article by Griffiths et al.

Gaudin P, Moutet F, Tuke PW, Garson JA.

Arthritis Rheum. 1999 Nov;42(11):2492-4. No abstract available.

13.

Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H.

Lancet. 1998 Jan 3;351(9095):33. No abstract available.

PMID:
9433428
14.

Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis.

Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B.

Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7583-8.

15.

Development of a pan-retrovirus detection system for multiple sclerosis studies.

Tuke PW, Perron H, Bedin F, Beseme F, Garson JA.

Acta Neurol Scand Suppl. 1997;169:16-21.

PMID:
9174636
16.

Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.

Ferns RB, Tuke PW, Sweenie CH.

J Med Virol. 1996 Nov;50(3):221-9.

PMID:
8923286
17.

Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.

Brennan M, Runganga J, Barbara JA, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JH, et al.

BMJ. 1993 Nov 13;307(6914):1235-9.

18.

Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients.

Makris M, Garson JA, Ring CJ, Tuke PW, Tedder RS, Preston FE.

Blood. 1993 Apr 1;81(7):1898-902.

PMID:
8384899
19.
20.

Improvement of HCV genome detection with "short" PCR products.

Garson JA, Ring CJ, Tuke PW.

Lancet. 1991 Dec 7;338(8780):1466-7. No abstract available.

PMID:
1683457
21.

HTLV-II infection in a Liverpool intravenous drug user.

Parry CM, Harries AD, Beeching NJ, Shaw IM, Mutton KJ, McAlpine L, Tosswill JH, Tuke PW, Garson JA.

J Infect. 1991 Nov;23(3):337-9. No abstract available.

PMID:
1753147
22.

Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia.

Tedder RS, Briggs M, Ring C, Tuke PW, Jones P, Savidge GF, Rodgers B, Garson JA.

Br J Haematol. 1991 Nov;79(3):512-5.

PMID:
1721527
23.

Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.

Brillanti S, Garson JA, Tuke PW, Ring C, Briggs M, Masci C, Miglioli M, Barbara L, Tedder RS.

J Med Virol. 1991 Jun;34(2):136-41.

PMID:
1716296
24.

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.

Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS.

Lancet. 1990 Oct 27;336(8722):1022-5.

PMID:
1977017

Supplemental Content

Support Center